Glucotrack, Inc. Files Exchange Agreement; Reports New Financial Obligation

What Happened

Glucotrack, Inc. (GCTK) filed a Form 8-K on July 29, 2026 to report entry into a material definitive agreement. The company executed an Exchange Agreement dated July 24, 2026 that supersedes and replaces in its entirety the Exchange Agreement dated July 22, 2026 previously filed. The amendment amends and restates the prior 8-K in its entirety and the new Exchange Agreement is filed as Exhibit 10.1 to the amendment.

Key Details

• Exchange Agreement dated July 24, 2026 was executed and replaces the July 22, 2026 Exchange Agreement previously filed as Exhibit 10.1.
• The amendment expressly amends and restates the Original Report in its entirety; the Original Exchange Agreement is superseded.
• The company reported the creation of a direct financial obligation (Item 2.03) in the filing; the Form 8-K references this obligation but does not detail amounts or terms in the text of the filing.
• Exhibit filed: Form of Exchange Agreement (Exhibit 10.1) dated July 24, 2026; the filing also includes the inline XBRL cover page.

Why It Matters

Replacing an earlier exchange agreement is a material corporate action that can change the rights or obligations associated with securities or related financial arrangements. The filing also notes a new direct financial obligation, which could affect the company’s liabilities. Retail investors should review the Exchange Agreement (Exhibit 10.1) to see the specific terms and assess any potential impact on equity holders or creditors.